SAN
FRANCISCO, May 25, 2022 /PRNewswire/ -- Tivic
Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase
health technology company that develops and commercializes
bioelectronic medicine, today announced survey findings revealing
that seasonal allergies impact job performance, commuting, and the
ability to enjoy outdoor activities.
A randomized survey of 2,000 U.S. allergy sufferers* was
conducted last month by OnePoll on behalf of Tivic Health and found
that 79 percent of respondents look forward to the changing
seasons, but not the potential allergies that come with it.
Seventy-six percent of respondents consider their allergies severe,
and 86 percent said sinus and allergy issues impact their job
performance. Forty-six percent of respondents said allergies even
affect their commute to work.
When asked about solutions for combating allergies, 63 percent
said natural and drug-free options impact their purchase decisions
and almost 5 in 10 (48 percent) said they spend $100 or more on over-the-counter allergy and
sinus medication each year.
"Allergy season began early this year, and with it comes an
increase in respiratory allergies caused by early pollination of
plants and trees," said Jennifer
Ernst, CEO of Tivic Health. "We continue to see via
testimonials and product reviews high consumer interest in products
that help them better manage their health and wellness.
"We believe that consumers need to have access to safe,
effective, and affordable options when searching for allergy
relief," continued Ernst. "We've taken a sophisticated technology
and delivered it via ClearUP, a non-invasive, drug-free device for
sinus pain and congestion from allergies, colds, and flu. ClearUP
is a bioelectronic device which works with the body's neural
pathways to target sinus pain and congestion."
It turns out that seasonal allergies are giving respondents more
trouble than just nasal drip, sinus pain and headaches. Half of the
respondents reported finding it difficult to walk their dog and 49
percent said outdoor activities, like hiking or boating, are
impacted by their allergies.
Dr. Alan Goldsobel of Allergy & Asthma Associates of
Northern California, and Adjunct
Clinical Professor at Stanford
University says, "A vast majority of patients are not
interested in taking more medications – steroids in particular –
and don't want to use nasal steroids even when
doctors recommend it."
Additional highlights from the survey include:
- 40 percent keep medications to combat their allergies on hand
year-round
- 44 percent begin adding to their stockpile several weeks before
allergy season begins and another 30 percent start months in
advance
- 53 percent will try an average of five or more remedies before
giving up and toughing out their allergies
- 73 percent would spend more than $100 for a non-drowsy, drug-free solution for
sinus pain and congestion
- 66 percent would be interested in using a drug-free device to
relieve sinus pain and congestion
- 56 percent seek out natural or non-invasive remedies to treat
their allergy symptoms.
ClearUP is available at https://tivichealth.com, Amazon.com, and
BestBuy.com, and has an MSRP of $149.
*About the Survey
The survey was conducted by
One Poll on behalf of Tivic Health,
April 11-12, 2022, and sent to 2000
respondents (demographics US population). Respondents were asked if
they suffer from allergies and were not compensated for their
participation.
About Tivic Health Systems, Inc.
Tivic Health Systems,
Inc. is a commercial-phase health technology company delivering
non-invasive bioelectronic treatments that provide consumers a
choice in the treatment of inflammation and related conditions. For
more information visit https://tivichealth.com @TivicHealth
Forward Looking Statements
This press release may
contain "forward-looking statements" that are subject to
substantial risks and uncertainties. All statements, other than
statements of historical fact, contained in this press release are
forward-looking statements. Forward-looking statements contained in
this press release may be identified by the use of words such as
"anticipate," "believe," "contemplate," "could," "estimate,"
"expect," "intend," "seek," "may," "might," "plan," "potential,"
"predict," "project," "target," "aim," "should," "will" "would," or
the negative of these words or other similar expressions, although
not all forward-looking statements contain these words.
Forward-looking statements are based on Tivic Health Systems,
Inc.'s current expectations and are subject to inherent
uncertainties, risks, and assumptions that are difficult to
predict. Further, certain forward-looking statements are based on
assumptions as to future events that may not prove to be accurate.
Additional information concerning Tivic Health and its business,
including a discussion of factors that could materially affect the
company operating results, is contained in the company's Annual
Report on Form 10-K for the year ended December 31, 2021, filed with the Securities and
Exchange Commission on March 31,
2022, under the heading "Risk Factors," as well as the
Company's subsequent filings with the Securities and Exchange
Commission. Forward-looking statements contained in this press
release are made as of this date, and Tivic Health Systems, Inc.
undertakes no duty to update such information except as required by
applicable law.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/tivic-health-survey-reveals-allergy-season-impacts-job-performance-commuting-and-ability-to-enjoy-outdoor-activities-301554538.html
SOURCE Tivic Health Systems Inc.